Selected – 2018

ERA-NET on Cardiovascular Diseases Joint Transnational Call for Proposals 2018 (JTC 2018): “Transnational Cardiovascular Research Projects driven by Early career scientists”

The ANR has teamed up with the ERA-NET ERA-CVD to launch a joint transnational call for proposals for funding of innovative research projects in cardiovascular diseases driven by early career scientists.

Seventeen countries are participating to this call for proposals: Austria, Belgium, Canada, Estonia, France, Germany, Italy, Latvia, Norway, Poland, Portugal, Romania, Slovakia, Spain, Taiwan, The Netherlands, and Turkey.

The JTC 2018 aims at enabling early career scientists from different countries to build an effective collaboration on common multidisciplinary research projects based on complementarities and sharing of expertise in all fields of cardiovascular research, with a clear translational research approach.

The ERA-CVD funding organizations particularly wish to promote multi-disciplinary work and translational research proposals. The individual components of joint applications should be complementary and contain novel, ambitious ideas to answer key questions or lead to a step-wise change in understanding of cardiovascular diseases. There should be a clear benefit in funding the collaboration over individual projects by sharing of resources (models, databases, diagnosis etc.), harmonisation of data, sharing of specific know-how and/or innovative technologies, etc. Applicants are encouraged to demonstrate engagement with clinics, patient organisations and small and medium-size enterprises (SME) for their active participation including sharing of resources, capabilities and expertise in order to ensure an efficient transfer of pre-clinical results into clinical utility.

Additionally, each proposal should consider the following cross-sectional aspects:

  • interdisciplinary approach, e.g. integrating biomedicine, physics, chemistry, mathematics, systems biology and clinical medicine for the development of the applications;
  • research on sex/gender differences in order to give further mechanistic insights into the development of the disease, its progression and to identify difference in treatment responses;
  • Translational research approach/perspective.

The following types of research projects are excluded from the call:

  • Interventional clinical trials;
  • Building up of new cohorts, registries and/or biomaterial banks;
  • Cerebrovascular and rheumatic diseases;
  • Research that primarily leads to cardiovascular risk management. Risk management is understood as long term health improvement and/or CAD prevention strategy;
  • Conducting screenings.

Only transnational projects will be funded. Each consortium submitting a proposal must involve a minimum of three (3) eligible partners and a maximum of five (5) eligible partners. Additionally, eligible partners must come from at least three (3) different countries participating in the call (see list above). No more than one partner from the same country or region participating in the call will be accepted per application. As an exception, two (2) research groups from Spain may be comprised in the same research consortium.

Consortia including partners from countries that are to date underrepresented in this funding scheme (Estonia, Latvia, Poland, Romania, Slovakia and Turkey) may increase the maximum total number of partners to six (6). One additional partner that provides his own funding may join consortia. Taking into account the above-mentioned rules, a consortium can have a maximum of seven (7) partners.

All proposal partners must be early career scientist. The early career scientist must have been awarded his/her first doctoral degree at least 3 and up to 10 years prior to the pre-proposal submission deadline of the ERA-CVD JTC 2018 call. Extensions to this eligibility period may be allowed in case of reasonably justified career breaks, which must be properly documented (maximum extension of up to 14 years after PhD). Applicants must have the necessary qualifications and the required infrastructure to perform the project. It is essential that applicants have published excellent work in international scientific journals or have made recognized contributions in the scientific community to the development of a particular field. Candidates must prove that they are scientifically independent, for example that they lead or have led a research group or project.

ANR will only fund young researchers that hold a permanent position in a public or assimilated research body, or within a company (in the latter case, the young researcher cannot be the project coordinator).

Funding will be awarded for a maximum of three years. The maximum funding for French partners is 250 000€. ANR funding will be limited to 250 000 € per French partner. In case if French team takes over the coordination of the project the maximum budget can be increased up to 300 000 €. The ANR will fund only the French partners in the selected projects.

ANR Funding Regulations that apply to this call are available here (in French):

Opening : 2018-01-22 at 11:46 CET
Pre-proposal deadline : 2018-03-15 at 17:00 CET
Application Deadline : 2018-06-15 at 17:00 CEST

The specific annex for French partners is available on this site. The call text, proposal template, and guidelines for applicants are available on this site or on

Research project consortia who intend to submit a transnational proposal should register as soon as possible at, by clicking on “to register” and following instructions. Electronic proposal submission is mandatory on this website.

The ANR will accept no direct proposal submissions.

Contact persons for the Joint Call Secretariat:

-Maria Grazia Mancini
E-mail: jcs-era(at)
Phone : +39 06 5994 3215
Ministero della Salute, Italy

-Dr. Hella Lichtenberg
E-mail: hella.lichtenberg(at)
Tel: +49 (0)228 3821-1157

ANR contact:

Dr. Deborah Zyss
+33 (0)1 78 09 81 74


Consult the upcoming and current calls of the portal

The portal centralises all information on calls for proposals and calls for applications from ADEME, ANR, Inserm including ANRS, Anses and INCa. It provides a simplified access to upcoming and ongoing calls, giving a greater visibility to funding opportunities. Following their closing date, the calls remain published for a few months.


Sign up for the latest news:
Subscribe to our newsletter